Vertical alliance networks: The case of university–biotechnology–pharmaceutical alliance chains

By Toby E. Stuart, Salih Zeki Ozdemir, Waverly W. Ding. 2007

298 citations recorded by the source corpus.

Subfields: Management of Technology and Innovation, Public Health, Environmental and Occupational Health, Strategy and Management

View Paper: https://www.semanticscholar.org/paper/b814d5fa3144f5f9b1abe300d9baf4d4499e7e4f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Management of Technology and Innovation

In Public Health, Environmental and Occupational Health

Albert N. Link

In Strategy and Management

Citations in the corpus

The role of entrepreneurial decision-making in opportunity creation and recognition (2015, background): “Many empirical studies tend to focus on the internal structures and mechanisms of translating scientific discovery into useful innovation (e.g. Stuart et al., 2007; Subramanian et al., 2013) and on the profiles or motivations of scientists to participate in commercialization activities, including…”
Fostering university-industry R&D collaborations in European Union countries (2015, background): “Our findings suggest that universities have to device more innovative approaches to access that targets businesses that are mature and large (Stuart et al. 2007, Fontana et al. 2006) and that are engaged in exploratory internal R&D (Bercovitz and Feldman 2007).”
Conveying Quality and Value in Emerging Industries: Star Scientists and the Role of Learning in Biotechnology (2011, unknown): “Moreover, the industry had developed into one that was facilitating the move of research out of universities and eventually to the pharmaceutical industry (Stuart et al., 2007).”
The contribution of university research to the growth of academic start-ups: an empirical analysis (2010, background): “As a corollary, ASUs may favor the circulation in the private sector of valuable knowledge generated within universities, playing a crucial bridging role (for a similar view see Stuart et al. 2007 ).”
What drives patent performance of German biotech firms? The impact of R&D subsidies, knowledge networks and their location (2011, background): “Hence, knowledge, especially in fields like biotechnology, is generated by close contact with other experts in the field largely based upon collaborative research (Owen-Smith and Powell 2004; Stuart et al. 2007).”